loading
전일 마감가:
$2.845
열려 있는:
$2.78
하루 거래량:
207.33K
Relative Volume:
0.08
시가총액:
$490.35M
수익:
$25.55M
순이익/손실:
$-341.97M
주가수익비율:
-1.0242
EPS:
-2.8
순현금흐름:
$-304.44M
1주 성능:
+2.18%
1개월 성능:
-7.68%
6개월 성능:
-39.55%
1년 성능:
-58.87%
1일 변동 폭
Value
$2.75
$2.90
1주일 범위
Value
$2.75
$3.16
52주 변동 폭
Value
$1.775
$10.72

릴레이 테라퓨틱스 Stock (RLAY) Company Profile

Name
명칭
Relay Therapeutics Inc
Name
전화
617-370-8837
Name
주소
399 BINNEY STREET, CAMBRIDGE
Name
직원
259
Name
트위터
Name
다음 수익 날짜
2025-02-21
Name
최신 SEC 제출 서류
Name
RLAY's Discussions on Twitter

RLAY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RLAY
Relay Therapeutics Inc
2.86 478.33M 25.55M -341.97M -304.44M -2.80
Biotechnology icon
ONC
Beigene Ltd Adr
240.88 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
432.88 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.33 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.19 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.16 5.92B 0 -153.72M -103.81M -2.00

릴레이 테라퓨틱스 Stock (RLAY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-17 개시 Wells Fargo Equal Weight
2024-09-10 재개 Goldman Buy
2024-09-10 업그레이드 Jefferies Hold → Buy
2024-09-10 다운그레이드 Oppenheimer Outperform → Perform
2024-05-10 업그레이드 Barclays Equal Weight → Overweight
2023-04-20 업그레이드 Jefferies Underperform → Hold
2023-04-19 업그레이드 Raymond James Outperform → Strong Buy
2023-04-13 개시 Raymond James Outperform
2023-02-03 개시 Oppenheimer Outperform
2022-09-30 개시 Barclays Equal Weight
2022-09-02 개시 Stifel Buy
2022-06-06 개시 Jefferies Underperform
2022-02-01 개시 Berenberg Buy
2021-07-21 개시 BofA Securities Buy
2020-12-15 재확인 H.C. Wainwright Buy
2020-12-08 개시 JMP Securities Mkt Outperform
2020-11-05 개시 H.C. Wainwright Buy
2020-08-10 개시 Cowen Outperform
2020-08-10 개시 Goldman Buy
2020-08-10 개시 Guggenheim Buy
2020-08-10 개시 JP Morgan Neutral
모두보기

릴레이 테라퓨틱스 주식(RLAY)의 최신 뉴스

pulisher
May 22, 2025

Northern Trust Corp Buys 231,713 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 22, 2025
pulisher
May 21, 2025

BNP Paribas Financial Markets Invests $987,000 in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 21, 2025
pulisher
May 17, 2025

Stifel Financial Corp Makes New Investment in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 17, 2025
pulisher
May 16, 2025

Layoff Tracker: Allogene Cuts 28% of Staff to Extend Runway, Focus on Clinical Programs - BioSpace

May 16, 2025
pulisher
May 16, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

May 16, 2025
pulisher
May 14, 2025

Transcript : Relay Therapeutics, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 03 - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Relay Therapeutics, Inc. (RLAY): One of the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance

May 13, 2025
pulisher
May 12, 2025

10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025
pulisher
May 12, 2025

HC Wainwright Issues Optimistic Forecast for RLAY Earnings - Defense World

May 12, 2025
pulisher
May 11, 2025

Relay Therapeutics, Inc. (RLAY): A Bull Case Theory - MSN

May 11, 2025
pulisher
May 11, 2025

89,949 Shares in Relay Therapeutics, Inc. (NASDAQ:RLAY) Purchased by First Trust Advisors LP - Defense World

May 11, 2025
pulisher
May 10, 2025

Dimensional Fund Advisors LP Grows Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 10, 2025
pulisher
May 09, 2025

Q2 EPS Estimate for Relay Therapeutics Lowered by Analyst - Defense World

May 09, 2025
pulisher
May 08, 2025

Relay Therapeutics to Participate in Two Upcoming Investor Conferences - The Manila Times

May 08, 2025
pulisher
May 08, 2025

Hsbc Holdings PLC Has $458,000 Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - The AM Reporter

May 08, 2025
pulisher
May 08, 2025

MetLife Investment Management LLC Grows Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 08, 2025
pulisher
May 07, 2025

Guggenheim Lowers Price Target for Relay Therapeutics (RLAY) to $10.00 | RLAY Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Relay Therapeutics (RLAY) Stock Target Reduced Amid Strategic Changes and Progress | RLAY Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Marshall Wace LLP Lowers Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 07, 2025
pulisher
May 07, 2025

Raymond James Financial Inc. Takes $779,000 Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 07, 2025
pulisher
May 07, 2025

Wells Fargo & Company MN Decreases Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 07, 2025
pulisher
May 06, 2025

Relay Therapeutics Inc (RLAY) Q1 2025 Earnings: EPS Loss of $0.4 - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Relay Therapeutics (RLAY) Reports Decline in Q1 Revenue | RLAY S - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Relay Therapeutics Extends Cash Runway and Advances Clinical Trials - TipRanks

May 06, 2025
pulisher
May 05, 2025

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates | RLAY Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics, Inc. SEC 10-Q Report - TradingView

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates - The Manila Times

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics Extends Cash Runway into 2029 Amid Clinical Trial Advancements - Nasdaq

May 05, 2025
pulisher
May 05, 2025

Barclays PLC Has $1.29 Million Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 05, 2025
pulisher
May 04, 2025

Invesco Ltd. Acquires 5,261 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 04, 2025
pulisher
May 02, 2025

There Is A Lot Of Upside Potential For Relay Therapeutics Inc(NASDAQ: RLAY) - Stocksregister

May 02, 2025
pulisher
May 01, 2025

why Relay Therapeutics Inc [RLAY] is a Good Choice for Investors After New Price Target of $17.40 - dbtnews.com

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics executive sells $36,540 in stock By Investing.com - Investing.com Nigeria

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics executive sells $36,540 in stock - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

LPL Financial LLC Sells 6,564 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics president sells $95,381 in stock By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics chief legal officer sells $44,040 in stock By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics CFO sells shares worth $44,246 By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
Apr 30, 2025

Relay Therapeutics Inc Stock: Executives Sell Shares Amid Mixed Signals - sharewise

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics president sells $95,381 in stock - Investing.com Australia

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics CFO sells shares worth $44,246 - Investing.com Australia

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics chief legal officer sells $44,040 in stock - Investing.com

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics Executives Sell Shares to Cover Tax Obligations and Under Trading Plan - TradingView

Apr 30, 2025
pulisher
Apr 30, 2025

Healthy Upside Potential: Relay Therapeutics Inc (RLAY) - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Trading Day Review: Relay Therapeutics Inc (RLAY) Loses Momentum, Closing at 3.10 - DWinneX

Apr 30, 2025

릴레이 테라퓨틱스 (RLAY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

릴레이 테라퓨틱스 주식 (RLAY) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Rahmer Peter
See remarks
Apr 28 '25
Sale
3.17
1,364
4,324
400,820
Catinazzo Thomas
Chief Financial Officer
Apr 30 '25
Sale
3.00
12,943
38,829
355,376
Catinazzo Thomas
Chief Financial Officer
Apr 29 '25
Sale
3.23
3,558
11,492
368,319
Catinazzo Thomas
Chief Financial Officer
Apr 28 '25
Sale
3.17
2,690
8,527
371,877
Bergstrom Donald A
President, R&D
Apr 30 '25
Sale
3.00
27,472
82,416
583,490
Bergstrom Donald A
President, R&D
Apr 28 '25
Sale
3.17
4,090
12,965
610,962
Adams Brian
Chief Legal Officer
Apr 30 '25
Sale
3.00
12,943
38,829
391,385
Adams Brian
Chief Legal Officer
Apr 28 '25
Sale
3.17
1,644
5,211
404,328
$1.19
price down icon 13.67%
$31.50
price down icon 3.35%
$578.71
price down icon 0.54%
$285.13
price down icon 1.30%
$4.10
price down icon 2.24%
$72.94
price down icon 0.11%
자본화:     |  볼륨(24시간):